Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNC000933

Drug Information

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
CAS NumberCAS 142155-43-9
PubChem Compound IDCID 126941.    
PubChem Substance IDSID 5042.    
SuperDrug ATC IDL01BA01;    
SuperDrug CAS ID000059052;    
TargetDihydrofolate reductaseInhibitor[1][2][3]
Ref 1Anticancer antifolates: current status and future directions. Curr Pharm Des. 2003;9(31):2593-613. To Reference
Ref 2Deaza analogs of folic acid as antitumor agents. Curr Pharm Des. 2003;9(31):2615-25. To Reference
Ref 3Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Int J Cancer. 2003 Feb 20;103(5):587-99. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543